Cargando…
Predictors of severe or lethal COVID-19, including Angiotensin Converting Enzyme inhibitors and Angiotensin II Receptor Blockers, in a sample of infected Italian citizens
AIMS: This retrospective case-control study was aimed at identifying potential independent predictors of severe/lethal COVID-19, including the treatment with Angiotensin-Converting Enzyme inhibitors (ACEi) and/or Angiotensin II Receptor Blockers (ARBs). METHODS AND RESULTS: All adults with SARS-CoV-...
Autores principales: | Bravi, Francesca, Flacco, Maria Elena, Carradori, Tiziano, Volta, Carlo Alberto, Cosenza, Giuseppe, De Togni, Aldo, Acuti Martellucci, Cecilia, Parruti, Giustino, Mantovani, Lorenzo, Manzoli, Lamberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314008/ https://www.ncbi.nlm.nih.gov/pubmed/32579597 http://dx.doi.org/10.1371/journal.pone.0235248 |
Ejemplares similares
-
Severe Acute Respiratory Syndrome Coronavirus 2 Lethality Did not Change Over Time in Two Italian Provinces
por: Flacco, Maria Elena, et al.
Publicado: (2020) -
Treatment with ACE inhibitors or ARBs and risk of severe/lethal COVID-19: a meta-analysis
por: Flacco, Maria Elena, et al.
Publicado: (2020) -
SARS-CoV-2 pandemic: An overview
por: Acuti Martellucci, Cecilia, et al.
Publicado: (2020) -
Inhaled CO(2) Concentration While Wearing Face Masks: A
Pilot Study Using Capnography
por: Acuti Martellucci, Cecilia, et al.
Publicado: (2022) -
Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)